TCL Archive “Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.” July 7, 1995
TCL Archive FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment. September 28, 2001
